and we use subgroup analysis to evaluate total obliteration, risk of hemorrhage, and complications of Grade III AVM radiosurgery.
Methods

Patient Population
Between 1987 and 2009, single-stage SRS was performed using the Leksell Gamma Knife (Elekta AB) in 474 patients with SM Grade III AVMs. Eighty-one patients (17%) underwent prior embolization and 58 (12%) underwent prior resection. The AVMs were categorized as follows: Grade IIIa denoted a small AVM (size < 3 cm, presence of deep venous drainage, critical location); Grade IIIb was a medium/deep AVM (size 3-6 cm, presence of deep venous drainage, noncritical location); Grade IIIc was a medium/eloquent AVM (size 3-6 cm, absence of deep venous drainage, critical location); and Grade IIId was a large AVM (size > 6 cm, absence of deep venous drainage, noncritical location). Of the 474 patients with SM Grade III AVMs, 282 (59%) had Grade IIIa, 44 (9%) had Grade IIIb, and 148 (31%) had Grade IIIc. No Grade IIId AVMs were treated in this study. A history of prior hemorrhage before SRS was seen in 74% of Grade IIIa AVMs, in 32% of Grade IIIb AVMs, and in 30% of Grade IIIc AVMs. The patient demographics and AVM characteristics are summarized in Table 1 .
Radiosurgery Technique
Our radiosurgical technique has been described in detail in previous reports. 10 The margin SRS dose was crafted to include the entire AVM nidus volume, defined as the shunt between the afferent arteries and draining veins. Successfully embolized volumes were not included in the SRS target volume. The SRS was performed with either a model U, B, C, or 4-C Leksell Gamma Knife (Elekta AB). The median diameter of the AVM nidus was 19 mm (range 6-29 mm) in Grade IIIa, 32 mm (range 30-47 mm) in Grade IIIb, and 30 mm (range 30-45 mm) in Grade IIIc. The median target volume was 2.2 ml in Grade IIIa, 7.7 ml in Grade IIIb, and 6.6 ml in Grade IIIc. The median margin dose was 20 Gy in Grade IIIa, 17 Gy in Grade IIIb, and 18 Gy in Grade IIIc.
Patient Follow-Up
After radiosurgery, patients were instructed to undergo clinical and imaging assessments at 6-, 12-, 24-, and 36-month intervals. At the end of 3 years, if MRI suggested complete obliteration, a follow-up angiogram was requested. Complete AVM obliteration was defined as no detectable residual nidus at the time of follow-up angiography, or no evidence of residual flow voids on contrast-enhanced T1-and T2-weighted MRI. Complete angiographic AVM obliteration was defined as disappearance of the nidus and absence of early venous drainage. At any time when a new neurological symptom or sign developed, the patient underwent CT and/or MRI studies to rule out hemorrhage or AREs. This retrospective study was approved by the University of Pittsburgh Institutional Review Board.
Statistical Analysis
Kaplan-Meier survival analysis was carried out to calculate rates of total obliteration and hemorrhage in each subgroup. Patients were censored when lost to follow-up or at the time of an event such as total obliteration and hemorrhage. Consequently, rates of hemorrhage reflect a single hemorrhage experienced by a patient even if he or she had more than one hemorrhage. Annual hemorrhage rates were calculated based on years of followup and total number of hemorrhages. The log-rank test was used to assess differences in survival curves, and Cox regression was used to assess hazard ratios (HRs) in multivariate analysis. A value of p < 0.05 was used for statistical significance.
Case Matching of SM Grade IIIb and IIIc AVMs
Forty-four patients with SM Grade IIIb AVMs were eligible to be case control matches in a comparison with 148 patients with SM Grade IIIc AVMs. Propensity score matching was performed between the SM Grade IIIb case cohort and the SM Grade IIIc control cohort. 2, 8, 9 The propensity score was calculated by fitting a logistic regression model in which the following 7 variables were used: age, number of prior hemorrhages, prior embolization, target volume, presence of coexisting aneurysm, radiosurgery-based AVM score, and follow-up duration. We used a nearest neighbor 1:2 matching algorithm based on the propensity score. After propensity score matching, the Mann-Whitney U-test for continuous data and the Fisher exact test for categorical data were used to compare both groups.
Results
At the time of assessment, 426 patients were alive and 48 had died. Twenty patients died of a brain hemorrhage, 1 patient died of untreated symptoms of AREs, and 27 patients died of causes unrelated to their AVM. The median follow-up after SRS was 89 months (range 2-278 months). All living patients had at least 1 year of imaging and clinical assessment.
Response to Radiosurgery
Obliteration of AVM was documented by MRI in 258 patients and by angiography in 198 patients at intervals that ranged from 3 to 10 years after SRS. The total obliteration rates (based on either angiography or MRI criteria) were 48% at 3 years, 69% at 4 years, 72% at 5 years, and 77% at 10 years. The total obliteration rates based on angiography alone were 39% at 3 years, 57% at 4 years, 59% at 5 years, and 62% at 10 years. Obliteration rates calculated by angiography alone in this experience are biased (artificially lowered) by the exclusion of patients with MRI-defined obliteration who declined to undergo angiography. The exact time of obliteration remains unknown because the timing of documentation by imaging varies. The 5-year total obliteration rates after SRS were 74% in Grade IIIa, 72% in Grade IIIb, and 69% in Grade IIIc (Fig. 1) .
In univariate analysis, factors associated with a higher rate of total obliteration on MRI included maximum diameter < 3 cm (Grade IIIa vs IIIb and IIIc) ( Fig.  1 Table  3 ). In patients with prior hemorrhage, the median target volume was 5.9 ml (range 0.17-26.3 ml), the median maximum diameter of the nidus was 2.8 cm (range 0.9-4.7 cm), and the median margin dose was 18.5 Gy (range 13.8-25.2 Gy). In patients without prior hemorrhage, the median target volume was 2.5 ml (range 0.1-18.6 ml), the median maximum diameter of the nidus was 2 cm (range 0.6-4.2 cm), and the median margin dose was 20 Gy (range 13-25 Gy). In patients with prior hemorrhage, this was significantly associated with smaller nidus volume (p < 0.001), smaller maximum diameter (p < 0.001), and higher margin dose (p < 0.001) than in those without prior hemorrhage.
Hemorrhage Before and After Radiosurgery
Thirty-four patients had 38 AVM hemorrhages after SRS. Two patients had 2 hemorrhages, the second of which was fatal in both patients. One patient had 3 hemorrhages and underwent repeat SRS at another hospital. Eighteen patients died after a single AVM hemorrhage at a median of 20 months (range 4-152 months) after SRS. The mortality rate due to AVM hemorrhage after SRS was 4.2%. In 1385 patient-years of estimated hemorrhage risk (the interval from the date of SRS to the date of total obliteration on angiography or the date of last followup imaging showing a residual AVM), we confirmed 38 hemorrhages, which corresponds to an annual hemorrhage rate of 2.7%.
In the 1st year after SRS (462.2 patient-years with 474 patients) 12 hemorrhages occurred; in the 2nd year (415 patient-years with 466 patients) 8 occurred; in the 3rd year (374.7 patient-years with 393 patients) 4 occurred; in the 4th-5th years (584 patient-years with 347 patients) 5 occurred; and in the 6th-10th years (875.7 patient-years with 252 patients) 5 hemorrhages occurred. The annual hemorrhage rates in patients without obliteration, in the interval of 0-1 year, was 2.6%, at 1-2 years it was 1.9%, at 2-3 years it was 1.1%, at 3-5 years it was 0.9%, and at Tables 2 and 3 . In univariate analysis, factors associated with an increased hemorrhage rate after SRS included older age, SM Grade IIIb (vs IIIa, IIIc, and IIIa plus IIIc) (Fig. 2) , presence of coexisting aneurysm, and higher radiosurgery-based AVM score. In multivariate analyses, factors associated with an increased hemorrhage rate after SRS included SM Grade IIIb (p = 0.016, HR 2.78, 95% CI 1.21-6.40), older age (p = 0.001, HR 1.04, 95% CI 1.02-1.06), and presence of coexisting aneurysm (p = 0.001, HR 3.65, 95% CI 1.62-8.22).
In the definition of SM Grade IIIb and IIIc the maximum diameter is the same (3-6 cm), but IIIb had deep venous drainage and IIIc had a critically located AVM.
Comparison of Outcomes of SM Grade IIIb and IIIc AVMs
We evaluated variables that might affect outcome differences between SM Grade IIIb (N = 44) and SM Grade IIIc AVMs (N = 148). In the definition of SM Grades IIIb and IIIc, the maximum diameter range is the same (3-6 cm). The SM Grade IIIb AVMs had deep venous drainage and IIIc AVMs had a location in an area of critical brain function. The SM Grade IIIb AVMs had larger target volumes (p = 0.031), larger maximum diameters (p < 0.001), lower margin doses (p = 0.001), and higher radiosurgerybased scores (p = 0.020) than those of SM Grade IIIc.
The demographic and clinical information of the SM Grade IIIb AVMs (cohort group: N = 44) was matched to the SM Grade IIIc AVMs (control group: N = 88), as shown in Table 4 . The radiosurgery-based AVM score (p = 0.545), target volume (p = 0.374), age (p = 0.225), presence of coexisting aneurysm (p = 0.319), and number of prior hemorrhages (p = 0.896) were no different between SM Grade IIIb and IIIc AVMs. We found no difference in the rate of total obliteration after SRS between SM Grade IIIb and IIIc (p = 0.239) after case matching.
In the control group of patients with SM Grade IIIb AVMs, postradiosurgery cumulative hemorrhage rates were 4.5% at 1 year, and 15% at 3 and 5 years. For patients with SM Grade IIIc AVMs, postradiosurgery cumulative hemorrhage rates were 1.1% at 1 year, 3.6% at 3 years, and 7.8% at 5 years (Fig. 2) . The patients with SM Grade IIIb AVMs had a higher rate of hemorrhage (log-rank test: p = 0.032; Cox proportional hazard test: p = 0.043, HR 3.3, 95% CI 1.04-10.3). Nine patients (1.9%) developed delayed cyst formation at a median of 28 months (range 6-210 months) after SRS. One patient required a craniotomy and cyst fenestration that resulted in clinical resolution of symptoms.
Adverse Radiation Effects
Additional Management
Fifty-nine patients with still patent AVMs underwent a second SRS procedure at a median of 42 months (range 18-263 months) after the first procedure. The prescription dose guidelines remained similar for both the initial and the subsequent SRS procedure. Thirty-four patients (58%) had total obliteration documented by MRI or angiography. Nine patients underwent a surgical procedure at a median of 24 months after SRS (range 2-179 months), either for hemorrhage (N = 8) or to obtain obliteration (N = 1). One patient underwent embolization for a coexisting aneurysm 25 months after SRS.
Discussion
Surgical Series of SM Grade III AVMs
Spetzler and Martin 20 reported a 16% rate of major and minor deficits after the resection of 25 Grade III AVMs. Heros et al. 7 reported a complication rate of 11.4% after resection of 44 SM Grade III AVMs. Lawton et al. 13 reported that 30% of 90 patients with SM Grade III AVMs were neurologically worse or dead after surgery. In the present series, 46 (9.7%) of 474 patients who underwent (AN[-] ). B: Kaplan-Meier curves for the hemorrhage rate after radiosurgery for AVMs with SM Grade IIIa (small) versus IIIb (medium/deep) versus IIIc (medium/eloquent). C: Kaplan-Meier curves for the hemorrhage rate after radiosurgery for AVMs with SM Grade IIIb (cohort) versus IIIc (control). The SM Grade IIIb AVM subgroup was significantly associated with a higher rate of hemorrhage.
SRS sustained a hemorrhage or permanent symptomatic AREs after treatment. During the latency interval 20 patients died of hemorrhage. The mortality rate was 4.2% and the morbidity rate was 5.5% in this study.
Radiosurgery Series of SM Grade III AVMs
Although the SM grading system is frequently used to describe results after AVM radiosurgery, additional factors critical to successful radiosurgery in these lesions are not relevant to this microsurgical grading system. 18 The major predictors of obliteration and complications following SRS are AVM volume, radiation dose, and AVM location. In contrast, the SM grading system is based on AVM size, deep venous draining, and critical location. Relatively few studies have used the SM grading system for predicting obliteration rates and outcome after SRS.
Subgroup Analysis of SM Grade III AVMs
A number of authors have suggested that the SM grading system should be modified to emphasize the differences within SM Grade III AVMs. De Oliveira et al. 4 divided SM Grade III AVMs into 2 subgroups based on AVM size. Their proposed subgroups were IIIA (large), for which they emphasized embolization followed by surgery; and IIIB (small, eloquent location), for which they proposed SRS. Lawton 12 suggested that SM Grade III AVMs be divided into 4 subgroups. His proposed subgroups of SM III AVMs were very similar to the subgroups evaluated in the present report. In the earlier series, the risk of permanent neurological morbidity or mortality associated with SM Grade IIIa AVMs was 2.9%, with SM Grade IIIb AVMs it was 7.8%, and with SM Grade IIIc AVMs it was 14.8%. Davidson and Morgan 3 reported that the surgical morbidity rate was 9% in 32 patients with SM Grade IIIa, 15% in 52 with SM Grade IIIb, 15% in 79 with SM Grade IIIc, and 17% in 6 patients with SM Grade IIId AVMs. Pandey et al. 17 estimated complication risks after combining 3 published series (Lawton, 12 Davidson and Morgan, 3 and Pandey et al.). In their report the complication rates were 4.8% in SM Grade IIIa, 14.4% in SM Grade IIIb, 15.7% in SM Grade IIIc, and 28.6% in SM Grade IIId AVMs. The combination of depth and critical location can be daunting and may make consideration of SRS as an alternative more appealing. 12 In the present series, 28 (9.9%) of 282 patients with SM Grade IIIa AVMs, 7 (15.9%) of 44 with SM Grade IIIb AVMs, and 11 (7.4%) of 148 with SM Grade IIIc AVMs developed either a hemorrhage or a permanent symptomatic ARE after SRS.
Andrade-Souza et al. 1 reported a radiation-induced complication rate of 25% for patients with SM Grade IIIa AVMs and 26.7% for patients with SM Grade IIIb and IIIc lesions in their series of LINAC-based SRS. In the present series, 10 (3.5%) of 282 patients with SM Grade IIIa AVMs, 0 (0%) of 44 with SM Grade IIIb AVMs, and 3 (2%) of 148 with SM Grade IIIc AVMs developed permanent symptomatic AREs after SRS.
Outcome Predictors
Lawton and colleagues 12, 13 reported that age, AVM size, unruptured presentation, and diffuse nidus were significant predictors of outcome, whereas critical location and deep venous drainage were borderline predictors of outcome. Pandey et al. 17 also found that an unruptured AVM was associated with a significantly higher incidence of new neurological deficits in their multimodality treatment series. In the present series, prior hemorrhage was associated with a higher rate of total obliteration, perhaps related to the fact that SM Grade IIIa (smaller size) AVMs generally received a higher margin SRS dose. Liscák et al.
14 also reported that prior hemorrhage was associated with higher rate of total obliteration. In our multivariate analysis, factors associated with a higher rate of total obliteration included higher margin dose and no prior embolization. Higher hemorrhage rates after SRS were associated with SM Grade IIIb, older age, and presence of a coexisting aneurysm. Age and a coexisting aneurysm were predictors of increased risk of hemorrhage after SRS in previous series. 9, 18 Prior to the present experience, SM Grade IIIb AVMs had not been reported as predictive of increased risk of hemorrhage after SRS. The SM Grade IIIb AVMs have significantly larger target volumes, larger maximum diameters, receive lower margin doses, and have higher radiosurgery-based AVM scores than SM Grade IIIc AVMs. These variables were considered as potential biases. Therefore, we performed a case-matching study of comparison between SM Grade IIIb and IIIc AVMs to reduce potential bias. Even after a case-matched control, patients with SM Grade IIIb AVMs had a higher rate of hemorrhage (p = 0.043, HR 3.3, 95% CI 1.04-10.3). In this study we could not determine whether the presence of deep venous drainage affected the risk of hemorrhage after SRS.
A Suggested Treatment Algorithm for SM Grade III AVMs
Grade III AVMs represent a heterogeneous group, with each subtype possessing different risks. Lawton 12 proposed that Grade IIIa AVMs safely undergo resection at experienced centers, whereas Grade IIIc AVMs may be better managed conservatively. The SM Grade IIIb AVMs require carefully individualized treatment recommendations and planning. De Oliveira et al. 5 recommended that patients with SM Grade IIIa AVMs should undergo embolization followed by surgery, whereas those with SM Grade IIIb and IIIc AVMs should undergo SRS. Our results suggest that SM Grade IIIa AVMs can be safely treated by SRS, and that SM Grade IIIb AVMs have a higher risk of hemorrhage after SRS compared with SM Grade IIIc lesions.
Weaknesses of the Present Study
We acknowledge the weaknesses of this retrospective outcome analysis. Although angiography is the gold standard for confirming obliteration, 25% of the patients in this series did not undergo angiography after their follow-up MRI revealed obliteration. Although the absence of follow-up angiography in these patients may lead to selection bias, we agree with Pollock et al., 19 who reported that only 3% of patients with MRI-defined obliteration had a residual nidus demonstrated by angiography. In this study we excluded patients who were lost to follow-up, a technique that might produce bias. Nevertheless, during our 25-year experience with AVMs, increasing experience with dose-volume relationships, conformality and selectivity of treatment planning, and reliance on both angiographic and then MRI data, gradually expanded our knowledge and improved SRS techniques and outcomes.
Conclusions
Treatment with SRS was an effective and relatively safe management option for SM Grade III AVMs. Although patients with residual AVMs remained at risk for hemorrhage during the latency interval after radiosurgery, the cumulative 10-year 9% hemorrhage risk in this series may represent a significant reduction compared with the expected natural history. Forty-six (9.7%) of 474 patients who underwent SRS developed hemorrhage or permanent symptomatic AREs after their treatment. It remains to be seen whether SM Grade IIIb AVMs have an increased the risk of hemorrhage during the latency interval after SRS.
